Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience Article Swipe
Giulio Cassanello
,
Esther Drill
,
Alfredo Rivas‐Delgado
,
Michelle Okwali
,
Irem Isgor
,
Philip Caron
,
Zachary D. Epstein‐Peterson
,
Paola Ghione
,
Paul A. Hamlin
,
Jennifer Kimberly Lue
,
Steven M. Horwitz
,
Andrew M. Intlekofer
,
William L. Johnson
,
Anita J. Kumar
,
Alison J. Moskowitz
,
Ariela Noy
,
Colette Owens
,
Lia Palomba
,
Pallawi Torka
,
Pallavi Galera
,
Andrew D. Zelenetz
,
Gilles Salles
,
Lorenzo Falchi
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3324/haematol.2024.285600
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3324/haematol.2024.285600
The combination of rituximab and lenalidomide (R-len) stands as an established treatment for relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL). However, the reproducibility of clinical trial results in routine clinical practice is unknown. To address this gap in knowledge, we reviewed our experience with patients diagnosed with R/R follicular lymphoma (FL) or marginal zone lymphoma (MZL) treated with this combination. Eighty-four patients underwent treatment with R-len, 69 (82%) affected by FL and 15 (18%) by MZL. The median age at the time of treatment initiation was 65 years (range, 39-94), 38 patients (45%) had a pre-treatment FLIPI score of 3-5, 19 (23%) had a bulky disease, 29 (37%) had a lymphoma refractory to the last treatment line, while in 20 (24%) cases the disease was refractory to rituximab. The best overall response rate (ORR) was 82%, and 52% achieved a complete response (CR). The best CR rates for FL and MZL patients were 55% and 40%, respectively. With a median follow-up of 22 months, the median progression-free survival (mPFS) was 22 months (95% CI 19-36) and the 2-year overall survival (OS) was 83% (95% CI 74-93). The median duration of CR (DoCR) was 46 months (95% CI 22-NR). Factors associated with shorter PFS in multivariate analysis were bulky disease and rituximab refractoriness. The most common adverse events (AE) included hematologic toxicity, fatigue and gastrointestinal disorders, such as diarrhea and constipation. Neutropenia and thrombocytopenia were the most common severe toxicities (grade ≥3 in 25% and 4%, respectively). No new safety signals were reported. Real-life results of R-len in patients with R/R iNHL appear consistent with those reported in prospective studies, and further support its use as comparator arm in controlled clinical trials.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- http://doi.org/10.3324/haematol.2024.285600
- OA Status
- gold
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4402259557
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4402259557Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3324/haematol.2024.285600Digital Object Identifier
- Title
-
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experienceWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-09-05Full publication date if available
- Authors
-
Giulio Cassanello, Esther Drill, Alfredo Rivas‐Delgado, Michelle Okwali, Irem Isgor, Philip Caron, Zachary D. Epstein‐Peterson, Paola Ghione, Paul A. Hamlin, Jennifer Kimberly Lue, Steven M. Horwitz, Andrew M. Intlekofer, William L. Johnson, Anita J. Kumar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Lia Palomba, Pallawi Torka, Pallavi Galera, Andrew D. Zelenetz, Gilles Salles, Lorenzo FalchiList of authors in order
- Landing page
-
https://doi.org/10.3324/haematol.2024.285600Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.3324/haematol.2024.285600Direct OA link when available
- Concepts
-
Medicine, Rituximab, Internal medicine, Neutropenia, Gastroenterology, Follicular lymphoma, Lenalidomide, Refractory (planetary science), Adverse effect, Lymphoma, Surgery, Multiple myeloma, Chemotherapy, Astrobiology, PhysicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4402259557 |
|---|---|
| doi | https://doi.org/10.3324/haematol.2024.285600 |
| ids.doi | https://doi.org/10.3324/haematol.2024.285600 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39234863 |
| ids.openalex | https://openalex.org/W4402259557 |
| fwci | 0.91580991 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D000069283 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Rituximab |
| mesh[2].qualifier_ui | Q000008 |
| mesh[2].descriptor_ui | D000069283 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | administration & dosage |
| mesh[2].descriptor_name | Rituximab |
| mesh[3].qualifier_ui | Q000009 |
| mesh[3].descriptor_ui | D000069283 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | adverse effects |
| mesh[3].descriptor_name | Rituximab |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D000077269 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Lenalidomide |
| mesh[5].qualifier_ui | Q000008 |
| mesh[5].descriptor_ui | D000077269 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | administration & dosage |
| mesh[5].descriptor_name | Lenalidomide |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D000077269 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Lenalidomide |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008875 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Middle Aged |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000368 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Aged |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008297 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Male |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D005260 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Female |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000328 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Adult |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000369 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Aged, 80 and over |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D000971 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[14].qualifier_ui | Q000009 |
| mesh[14].descriptor_ui | D000971 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | adverse effects |
| mesh[14].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D008228 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Lymphoma, Non-Hodgkin |
| mesh[16].qualifier_ui | Q000401 |
| mesh[16].descriptor_ui | D008228 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | mortality |
| mesh[16].descriptor_name | Lymphoma, Non-Hodgkin |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D016896 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Treatment Outcome |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D019008 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Drug Resistance, Neoplasm |
| mesh[19].qualifier_ui | Q000188 |
| mesh[19].descriptor_ui | D008224 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | drug therapy |
| mesh[19].descriptor_name | Lymphoma, Follicular |
| mesh[20].qualifier_ui | Q000401 |
| mesh[20].descriptor_ui | D008224 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | mortality |
| mesh[20].descriptor_name | Lymphoma, Follicular |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D012008 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Recurrence |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D012189 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Retrospective Studies |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | Q000627 |
| mesh[24].descriptor_ui | D000069283 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | therapeutic use |
| mesh[24].descriptor_name | Rituximab |
| mesh[25].qualifier_ui | Q000008 |
| mesh[25].descriptor_ui | D000069283 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | administration & dosage |
| mesh[25].descriptor_name | Rituximab |
| mesh[26].qualifier_ui | Q000009 |
| mesh[26].descriptor_ui | D000069283 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | adverse effects |
| mesh[26].descriptor_name | Rituximab |
| mesh[27].qualifier_ui | Q000627 |
| mesh[27].descriptor_ui | D000077269 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | therapeutic use |
| mesh[27].descriptor_name | Lenalidomide |
| mesh[28].qualifier_ui | Q000008 |
| mesh[28].descriptor_ui | D000077269 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | administration & dosage |
| mesh[28].descriptor_name | Lenalidomide |
| mesh[29].qualifier_ui | Q000009 |
| mesh[29].descriptor_ui | D000077269 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | adverse effects |
| mesh[29].descriptor_name | Lenalidomide |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D008875 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Middle Aged |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D008297 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Male |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D005260 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Female |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000328 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Adult |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000369 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Aged, 80 and over |
| mesh[36].qualifier_ui | Q000627 |
| mesh[36].descriptor_ui | D000971 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | therapeutic use |
| mesh[36].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[37].qualifier_ui | Q000009 |
| mesh[37].descriptor_ui | D000971 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | adverse effects |
| mesh[37].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D008228 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | Lymphoma, Non-Hodgkin |
| mesh[39].qualifier_ui | Q000401 |
| mesh[39].descriptor_ui | D008228 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | mortality |
| mesh[39].descriptor_name | Lymphoma, Non-Hodgkin |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D016896 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Treatment Outcome |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D019008 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Drug Resistance, Neoplasm |
| mesh[42].qualifier_ui | Q000188 |
| mesh[42].descriptor_ui | D008224 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | drug therapy |
| mesh[42].descriptor_name | Lymphoma, Follicular |
| mesh[43].qualifier_ui | Q000401 |
| mesh[43].descriptor_ui | D008224 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | mortality |
| mesh[43].descriptor_name | Lymphoma, Follicular |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D012008 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Recurrence |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D012189 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Retrospective Studies |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D006801 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Humans |
| mesh[47].qualifier_ui | Q000627 |
| mesh[47].descriptor_ui | D000069283 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | therapeutic use |
| mesh[47].descriptor_name | Rituximab |
| mesh[48].qualifier_ui | Q000008 |
| mesh[48].descriptor_ui | D000069283 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | administration & dosage |
| mesh[48].descriptor_name | Rituximab |
| mesh[49].qualifier_ui | Q000009 |
| mesh[49].descriptor_ui | D000069283 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | adverse effects |
| mesh[49].descriptor_name | Rituximab |
| type | article |
| title | Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience |
| biblio.issue | 2 |
| biblio.volume | 110 |
| biblio.last_page | 447 |
| biblio.first_page | 439 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T11157 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9898999929428101 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Chronic Lymphocytic Leukemia Research |
| topics[2].id | https://openalex.org/T10685 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9891999959945679 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Viral-associated cancers and disorders |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2157 |
| apc_paid.value | 2000 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2157 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8899307250976562 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780653079 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7827070951461792 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q412323 |
| concepts[1].display_name | Rituximab |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.7569956183433533 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C2777063308 |
| concepts[3].level | 3 |
| concepts[3].score | 0.66005939245224 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1435822 |
| concepts[3].display_name | Neutropenia |
| concepts[4].id | https://openalex.org/C90924648 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6242087483406067 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[4].display_name | Gastroenterology |
| concepts[5].id | https://openalex.org/C2777058707 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5758064985275269 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q123251 |
| concepts[5].display_name | Follicular lymphoma |
| concepts[6].id | https://openalex.org/C2776063141 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5508272647857666 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q425681 |
| concepts[6].display_name | Lenalidomide |
| concepts[7].id | https://openalex.org/C142424586 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5201940536499023 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7307572 |
| concepts[7].display_name | Refractory (planetary science) |
| concepts[8].id | https://openalex.org/C197934379 |
| concepts[8].level | 2 |
| concepts[8].score | 0.48965126276016235 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[8].display_name | Adverse effect |
| concepts[9].id | https://openalex.org/C2779338263 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4763232171535492 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[9].display_name | Lymphoma |
| concepts[10].id | https://openalex.org/C141071460 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3960198163986206 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[10].display_name | Surgery |
| concepts[11].id | https://openalex.org/C2776364478 |
| concepts[11].level | 2 |
| concepts[11].score | 0.3380017876625061 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q467635 |
| concepts[11].display_name | Multiple myeloma |
| concepts[12].id | https://openalex.org/C2776694085 |
| concepts[12].level | 2 |
| concepts[12].score | 0.23215284943580627 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[12].display_name | Chemotherapy |
| concepts[13].id | https://openalex.org/C87355193 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q411 |
| concepts[13].display_name | Astrobiology |
| concepts[14].id | https://openalex.org/C121332964 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[14].display_name | Physics |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8899307250976562 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/rituximab |
| keywords[1].score | 0.7827070951461792 |
| keywords[1].display_name | Rituximab |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.7569956183433533 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/neutropenia |
| keywords[3].score | 0.66005939245224 |
| keywords[3].display_name | Neutropenia |
| keywords[4].id | https://openalex.org/keywords/gastroenterology |
| keywords[4].score | 0.6242087483406067 |
| keywords[4].display_name | Gastroenterology |
| keywords[5].id | https://openalex.org/keywords/follicular-lymphoma |
| keywords[5].score | 0.5758064985275269 |
| keywords[5].display_name | Follicular lymphoma |
| keywords[6].id | https://openalex.org/keywords/lenalidomide |
| keywords[6].score | 0.5508272647857666 |
| keywords[6].display_name | Lenalidomide |
| keywords[7].id | https://openalex.org/keywords/refractory |
| keywords[7].score | 0.5201940536499023 |
| keywords[7].display_name | Refractory (planetary science) |
| keywords[8].id | https://openalex.org/keywords/adverse-effect |
| keywords[8].score | 0.48965126276016235 |
| keywords[8].display_name | Adverse effect |
| keywords[9].id | https://openalex.org/keywords/lymphoma |
| keywords[9].score | 0.4763232171535492 |
| keywords[9].display_name | Lymphoma |
| keywords[10].id | https://openalex.org/keywords/surgery |
| keywords[10].score | 0.3960198163986206 |
| keywords[10].display_name | Surgery |
| keywords[11].id | https://openalex.org/keywords/multiple-myeloma |
| keywords[11].score | 0.3380017876625061 |
| keywords[11].display_name | Multiple myeloma |
| keywords[12].id | https://openalex.org/keywords/chemotherapy |
| keywords[12].score | 0.23215284943580627 |
| keywords[12].display_name | Chemotherapy |
| language | en |
| locations[0].id | doi:10.3324/haematol.2024.285600 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2752781272 |
| locations[0].source.issn | 0390-6078, 1592-8721 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0390-6078 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Haematologica |
| locations[0].source.host_organization | https://openalex.org/P4310317774 |
| locations[0].source.host_organization_name | Ferrata Storti Foundation |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310317774 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Haematologica |
| locations[0].landing_page_url | http://doi.org/10.3324/haematol.2024.285600 |
| locations[1].id | pmid:39234863 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Haematologica |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39234863 |
| locations[2].id | pmh:oai:doaj.org/article:165097c826464008a67270b7f0865d5a |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Haematologica, Vol 999, Iss 1 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/165097c826464008a67270b7f0865d5a |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11788635 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Haematologica |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11788635 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5029998285 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2192-9930 |
| authorships[0].author.display_name | Giulio Cassanello |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan. |
| authorships[0].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[0].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Giulio Cassanello |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan. |
| authorships[1].author.id | https://openalex.org/A5048118946 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3315-4538 |
| authorships[1].author.display_name | Esther Drill |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. |
| authorships[1].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[1].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Esther Drill |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. |
| authorships[2].author.id | https://openalex.org/A5062538385 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0385-3415 |
| authorships[2].author.display_name | Alfredo Rivas‐Delgado |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY. |
| authorships[2].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[2].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Alfredo Rivas-Delgado |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY. |
| authorships[3].author.id | https://openalex.org/A5057291006 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Michelle Okwali |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY. |
| authorships[3].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[3].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Michelle Okwali |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY. |
| authorships[4].author.id | https://openalex.org/A5005153884 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7996-2250 |
| authorships[4].author.display_name | Irem Isgor |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. |
| authorships[4].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[4].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Irem Isgor |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. |
| authorships[5].author.id | https://openalex.org/A5076564214 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Philip Caron |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[5].institutions[0].id | https://openalex.org/I205783295 |
| authorships[5].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Cornell University |
| authorships[5].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[5].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Philip C Caron |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[6].author.id | https://openalex.org/A5059635097 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Zachary D. Epstein‐Peterson |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[6].institutions[0].id | https://openalex.org/I205783295 |
| authorships[6].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Cornell University |
| authorships[6].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[6].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Zachary Epstein-Peterson |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[7].author.id | https://openalex.org/A5016042168 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-6986-7954 |
| authorships[7].author.display_name | Paola Ghione |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[7].institutions[0].id | https://openalex.org/I205783295 |
| authorships[7].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Cornell University |
| authorships[7].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[7].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[7].institutions[1].country_code | US |
| authorships[7].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Paola Ghione |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[8].author.id | https://openalex.org/A5012810450 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9500-1804 |
| authorships[8].author.display_name | Paul A. Hamlin |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[8].institutions[0].id | https://openalex.org/I205783295 |
| authorships[8].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Cornell University |
| authorships[8].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[8].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[8].institutions[1].country_code | US |
| authorships[8].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Paul Hamlin |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[9].author.id | https://openalex.org/A5028291843 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8153-1820 |
| authorships[9].author.display_name | Jennifer Kimberly Lue |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[9].institutions[0].id | https://openalex.org/I205783295 |
| authorships[9].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Cornell University |
| authorships[9].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[9].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[9].institutions[1].country_code | US |
| authorships[9].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Jennifer Lue |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[10].author.id | https://openalex.org/A5069406522 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-6399-2006 |
| authorships[10].author.display_name | Steven M. Horwitz |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[10].institutions[0].id | https://openalex.org/I205783295 |
| authorships[10].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Cornell University |
| authorships[10].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[10].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[10].institutions[1].type | healthcare |
| authorships[10].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Steven M Horwitz |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[11].author.id | https://openalex.org/A5042981870 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-9046-6549 |
| authorships[11].author.display_name | Andrew M. Intlekofer |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[11].institutions[0].id | https://openalex.org/I205783295 |
| authorships[11].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Cornell University |
| authorships[11].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[11].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[11].institutions[1].country_code | US |
| authorships[11].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Andrew M Intlekofer |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[12].author.id | https://openalex.org/A5063628099 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2616-2553 |
| authorships[12].author.display_name | William L. Johnson |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[12].institutions[0].id | https://openalex.org/I205783295 |
| authorships[12].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Cornell University |
| authorships[12].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[12].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[12].institutions[1].type | healthcare |
| authorships[12].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[12].institutions[1].country_code | US |
| authorships[12].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | William Johnson |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[13].author.id | https://openalex.org/A5014933224 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8704-0296 |
| authorships[13].author.display_name | Anita J. Kumar |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[13].institutions[0].id | https://openalex.org/I205783295 |
| authorships[13].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Cornell University |
| authorships[13].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[13].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[13].institutions[1].country_code | US |
| authorships[13].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Anita Kumar |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[14].author.id | https://openalex.org/A5062879857 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-3408-050X |
| authorships[14].author.display_name | Alison J. Moskowitz |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[14].institutions[0].id | https://openalex.org/I205783295 |
| authorships[14].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Cornell University |
| authorships[14].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[14].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[14].institutions[1].country_code | US |
| authorships[14].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Alison Moskowitz |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[15].author.id | https://openalex.org/A5014543424 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-3001-4898 |
| authorships[15].author.display_name | Ariela Noy |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[15].institutions[0].id | https://openalex.org/I205783295 |
| authorships[15].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Cornell University |
| authorships[15].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[15].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[15].institutions[1].type | healthcare |
| authorships[15].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[15].institutions[1].country_code | US |
| authorships[15].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Ariela Noy |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[16].author.id | https://openalex.org/A5055986807 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Colette Owens |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan. |
| authorships[16].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[16].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Colette Owens |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan. |
| authorships[17].author.id | https://openalex.org/A5025530836 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Lia Palomba |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[17].institutions[0].id | https://openalex.org/I205783295 |
| authorships[17].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Cornell University |
| authorships[17].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[17].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[17].institutions[1].type | healthcare |
| authorships[17].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[17].institutions[1].country_code | US |
| authorships[17].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Lia M Palomba |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[18].author.id | https://openalex.org/A5050643493 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-1681-5883 |
| authorships[18].author.display_name | Pallawi Torka |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[18].institutions[0].id | https://openalex.org/I205783295 |
| authorships[18].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Cornell University |
| authorships[18].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[18].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[18].institutions[1].type | healthcare |
| authorships[18].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[18].institutions[1].country_code | US |
| authorships[18].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Pallawi Torka |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[19].author.id | https://openalex.org/A5072027170 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-9645-4426 |
| authorships[19].author.display_name | Pallavi Galera |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[19].affiliations[0].raw_affiliation_string | Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[19].institutions[0].id | https://openalex.org/I205783295 |
| authorships[19].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Cornell University |
| authorships[19].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[19].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[19].institutions[1].type | healthcare |
| authorships[19].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[19].institutions[1].country_code | US |
| authorships[19].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Pallavi Galera |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[20].author.id | https://openalex.org/A5061964017 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-1403-6883 |
| authorships[20].author.display_name | Andrew D. Zelenetz |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[20].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[20].institutions[0].id | https://openalex.org/I205783295 |
| authorships[20].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[20].institutions[0].type | education |
| authorships[20].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | Cornell University |
| authorships[20].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[20].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[20].institutions[1].type | healthcare |
| authorships[20].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[20].institutions[1].country_code | US |
| authorships[20].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Andrew D Zelenetz |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[21].author.id | https://openalex.org/A5086354986 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-9541-8666 |
| authorships[21].author.display_name | Gilles Salles |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[21].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[21].institutions[0].id | https://openalex.org/I205783295 |
| authorships[21].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[21].institutions[0].type | education |
| authorships[21].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | Cornell University |
| authorships[21].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[21].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[21].institutions[1].type | healthcare |
| authorships[21].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[21].institutions[1].country_code | US |
| authorships[21].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Gilles Salles |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. |
| authorships[22].author.id | https://openalex.org/A5090759974 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-1531-3838 |
| authorships[22].author.display_name | Lorenzo Falchi |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I1334819555, https://openalex.org/I205783295 |
| authorships[22].affiliations[0].raw_affiliation_string | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. [email protected]. |
| authorships[22].institutions[0].id | https://openalex.org/I205783295 |
| authorships[22].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[22].institutions[0].type | education |
| authorships[22].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Cornell University |
| authorships[22].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[22].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[22].institutions[1].type | healthcare |
| authorships[22].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[22].institutions[1].country_code | US |
| authorships[22].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[22].author_position | last |
| authorships[22].raw_author_name | Lorenzo Falchi |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY. [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.3324/haematol.2024.285600 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2215729572, https://openalex.org/W2062566755, https://openalex.org/W3217566318, https://openalex.org/W3126730168, https://openalex.org/W2052365909, https://openalex.org/W4297237848, https://openalex.org/W2167103668, https://openalex.org/W2084396664, https://openalex.org/W4238057170, https://openalex.org/W2051109119 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3324/haematol.2024.285600 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2752781272 |
| best_oa_location.source.issn | 0390-6078, 1592-8721 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0390-6078 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Haematologica |
| best_oa_location.source.host_organization | https://openalex.org/P4310317774 |
| best_oa_location.source.host_organization_name | Ferrata Storti Foundation |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310317774 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Haematologica |
| best_oa_location.landing_page_url | http://doi.org/10.3324/haematol.2024.285600 |
| primary_location.id | doi:10.3324/haematol.2024.285600 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2752781272 |
| primary_location.source.issn | 0390-6078, 1592-8721 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0390-6078 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Haematologica |
| primary_location.source.host_organization | https://openalex.org/P4310317774 |
| primary_location.source.host_organization_name | Ferrata Storti Foundation |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310317774 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Haematologica |
| primary_location.landing_page_url | http://doi.org/10.3324/haematol.2024.285600 |
| publication_date | 2024-09-05 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 93, 102, 108, 138, 157 |
| abstract_inverted_index.15 | 71 |
| abstract_inverted_index.19 | 99 |
| abstract_inverted_index.20 | 118 |
| abstract_inverted_index.22 | 161, 169 |
| abstract_inverted_index.29 | 105 |
| abstract_inverted_index.38 | 89 |
| abstract_inverted_index.46 | 192 |
| abstract_inverted_index.65 | 85 |
| abstract_inverted_index.69 | 65 |
| abstract_inverted_index.CI | 172, 183, 195 |
| abstract_inverted_index.CR | 144, 189 |
| abstract_inverted_index.FL | 69, 147 |
| abstract_inverted_index.No | 245 |
| abstract_inverted_index.To | 32 |
| abstract_inverted_index.an | 9 |
| abstract_inverted_index.as | 8, 225, 273 |
| abstract_inverted_index.at | 78 |
| abstract_inverted_index.by | 68, 73 |
| abstract_inverted_index.in | 26, 36, 117, 202, 240, 255, 265, 276 |
| abstract_inverted_index.is | 30 |
| abstract_inverted_index.of | 2, 22, 81, 97, 160, 188, 253 |
| abstract_inverted_index.or | 50 |
| abstract_inverted_index.to | 111, 125 |
| abstract_inverted_index.we | 38 |
| abstract_inverted_index.25% | 241 |
| abstract_inverted_index.4%, | 243 |
| abstract_inverted_index.52% | 136 |
| abstract_inverted_index.55% | 152 |
| abstract_inverted_index.83% | 181 |
| abstract_inverted_index.MZL | 149 |
| abstract_inverted_index.PFS | 201 |
| abstract_inverted_index.R/R | 46, 258 |
| abstract_inverted_index.The | 0, 75, 127, 142, 185, 211 |
| abstract_inverted_index.age | 77 |
| abstract_inverted_index.and | 4, 70, 135, 148, 153, 174, 208, 221, 227, 230, 242, 268 |
| abstract_inverted_index.arm | 275 |
| abstract_inverted_index.for | 12, 146 |
| abstract_inverted_index.gap | 35 |
| abstract_inverted_index.had | 92, 101, 107 |
| abstract_inverted_index.its | 271 |
| abstract_inverted_index.new | 246 |
| abstract_inverted_index.our | 40 |
| abstract_inverted_index.the | 20, 79, 112, 121, 163, 175, 233 |
| abstract_inverted_index.use | 272 |
| abstract_inverted_index.was | 84, 123, 133, 168, 180, 191 |
| abstract_inverted_index.(95% | 171, 182, 194 |
| abstract_inverted_index.(AE) | 216 |
| abstract_inverted_index.(FL) | 49 |
| abstract_inverted_index.(OS) | 179 |
| abstract_inverted_index.3-5, | 98 |
| abstract_inverted_index.40%, | 154 |
| abstract_inverted_index.82%, | 134 |
| abstract_inverted_index.MZL. | 74 |
| abstract_inverted_index.With | 156 |
| abstract_inverted_index.best | 128, 143 |
| abstract_inverted_index.iNHL | 259 |
| abstract_inverted_index.last | 113 |
| abstract_inverted_index.most | 212, 234 |
| abstract_inverted_index.rate | 131 |
| abstract_inverted_index.such | 224 |
| abstract_inverted_index.this | 34, 57 |
| abstract_inverted_index.time | 80 |
| abstract_inverted_index.were | 151, 205, 232, 249 |
| abstract_inverted_index.with | 42, 45, 56, 63, 199, 257, 262 |
| abstract_inverted_index.zone | 52 |
| abstract_inverted_index.≥3 | 239 |
| abstract_inverted_index.(18%) | 72 |
| abstract_inverted_index.(23%) | 100 |
| abstract_inverted_index.(24%) | 119 |
| abstract_inverted_index.(37%) | 106 |
| abstract_inverted_index.(45%) | 91 |
| abstract_inverted_index.(82%) | 66 |
| abstract_inverted_index.(CR). | 141 |
| abstract_inverted_index.(MZL) | 54 |
| abstract_inverted_index.(ORR) | 132 |
| abstract_inverted_index.(R/R) | 14 |
| abstract_inverted_index.FLIPI | 95 |
| abstract_inverted_index.R-len | 254 |
| abstract_inverted_index.bulky | 103, 206 |
| abstract_inverted_index.cases | 120 |
| abstract_inverted_index.line, | 115 |
| abstract_inverted_index.rates | 145 |
| abstract_inverted_index.score | 96 |
| abstract_inverted_index.those | 263 |
| abstract_inverted_index.trial | 24 |
| abstract_inverted_index.while | 116 |
| abstract_inverted_index.years | 86 |
| abstract_inverted_index.(DoCR) | 190 |
| abstract_inverted_index.(grade | 238 |
| abstract_inverted_index.(mPFS) | 167 |
| abstract_inverted_index.19-36) | 173 |
| abstract_inverted_index.2-year | 176 |
| abstract_inverted_index.R-len, | 64 |
| abstract_inverted_index.appear | 260 |
| abstract_inverted_index.common | 213, 235 |
| abstract_inverted_index.events | 215 |
| abstract_inverted_index.median | 76, 158, 164, 186 |
| abstract_inverted_index.months | 170, 193 |
| abstract_inverted_index.safety | 247 |
| abstract_inverted_index.severe | 236 |
| abstract_inverted_index.stands | 7 |
| abstract_inverted_index.(R-len) | 6 |
| abstract_inverted_index.(iNHL). | 18 |
| abstract_inverted_index.(range, | 87 |
| abstract_inverted_index.22-NR). | 196 |
| abstract_inverted_index.39-94), | 88 |
| abstract_inverted_index.74-93). | 184 |
| abstract_inverted_index.Factors | 197 |
| abstract_inverted_index.address | 33 |
| abstract_inverted_index.adverse | 214 |
| abstract_inverted_index.disease | 122, 207 |
| abstract_inverted_index.fatigue | 220 |
| abstract_inverted_index.further | 269 |
| abstract_inverted_index.months, | 162 |
| abstract_inverted_index.overall | 129, 177 |
| abstract_inverted_index.results | 25, 252 |
| abstract_inverted_index.routine | 27 |
| abstract_inverted_index.shorter | 200 |
| abstract_inverted_index.signals | 248 |
| abstract_inverted_index.support | 270 |
| abstract_inverted_index.treated | 55 |
| abstract_inverted_index.trials. | 279 |
| abstract_inverted_index.However, | 19 |
| abstract_inverted_index.achieved | 137 |
| abstract_inverted_index.affected | 67 |
| abstract_inverted_index.analysis | 204 |
| abstract_inverted_index.clinical | 23, 28, 278 |
| abstract_inverted_index.complete | 139 |
| abstract_inverted_index.diarrhea | 226 |
| abstract_inverted_index.disease, | 104 |
| abstract_inverted_index.duration | 187 |
| abstract_inverted_index.included | 217 |
| abstract_inverted_index.indolent | 15 |
| abstract_inverted_index.lymphoma | 17, 48, 53, 109 |
| abstract_inverted_index.marginal | 51 |
| abstract_inverted_index.patients | 43, 60, 90, 150, 256 |
| abstract_inverted_index.practice | 29 |
| abstract_inverted_index.reported | 264 |
| abstract_inverted_index.response | 130, 140 |
| abstract_inverted_index.reviewed | 39 |
| abstract_inverted_index.studies, | 267 |
| abstract_inverted_index.survival | 166, 178 |
| abstract_inverted_index.unknown. | 31 |
| abstract_inverted_index.Real-life | 251 |
| abstract_inverted_index.diagnosed | 44 |
| abstract_inverted_index.follow-up | 159 |
| abstract_inverted_index.reported. | 250 |
| abstract_inverted_index.rituximab | 3, 209 |
| abstract_inverted_index.toxicity, | 219 |
| abstract_inverted_index.treatment | 11, 62, 82, 114 |
| abstract_inverted_index.underwent | 61 |
| abstract_inverted_index.associated | 198 |
| abstract_inverted_index.comparator | 274 |
| abstract_inverted_index.consistent | 261 |
| abstract_inverted_index.controlled | 277 |
| abstract_inverted_index.disorders, | 223 |
| abstract_inverted_index.experience | 41 |
| abstract_inverted_index.follicular | 47 |
| abstract_inverted_index.initiation | 83 |
| abstract_inverted_index.knowledge, | 37 |
| abstract_inverted_index.refractory | 110, 124 |
| abstract_inverted_index.rituximab. | 126 |
| abstract_inverted_index.toxicities | 237 |
| abstract_inverted_index.Eighty-four | 59 |
| abstract_inverted_index.Neutropenia | 229 |
| abstract_inverted_index.combination | 1 |
| abstract_inverted_index.established | 10 |
| abstract_inverted_index.hematologic | 218 |
| abstract_inverted_index.non-Hodgkin | 16 |
| abstract_inverted_index.prospective | 266 |
| abstract_inverted_index.combination. | 58 |
| abstract_inverted_index.lenalidomide | 5 |
| abstract_inverted_index.multivariate | 203 |
| abstract_inverted_index.constipation. | 228 |
| abstract_inverted_index.pre-treatment | 94 |
| abstract_inverted_index.respectively. | 155 |
| abstract_inverted_index.respectively). | 244 |
| abstract_inverted_index.refractoriness. | 210 |
| abstract_inverted_index.reproducibility | 21 |
| abstract_inverted_index.gastrointestinal | 222 |
| abstract_inverted_index.progression-free | 165 |
| abstract_inverted_index.thrombocytopenia | 231 |
| abstract_inverted_index.relapsed/refractory | 13 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 23 |
| citation_normalized_percentile.value | 0.6861273 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |